This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Epilepsy and levonorgestrel releasing intra-uterine contraceptive device

Authoring team

NICE state that (1):

  • the use of additional barrier methods should be discussed with women and girls taking enzyme-inducing anti-epileptic drugs (AEDs) and oral contraception or having depot injections of progestogen

However FSRH guidance states with respect to depot medroxyprogesterone acetate (DMPA) or the levonorgestrel-releasing intrauterine system; used concurrently with enzyme-inducing AEDs

  • no interaction and no need for extra precautions

Reference:

  1. NICE (April 2018).The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care.
  2. Faculty of Sexual & Reproductive Healthcare Clinical Guidance.Clinical Guidance: Drug Interactions with Hormonal Contraception January 2018.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.